RESUMEN
Glycosaminoglycan (GAG) sequences that selectively target heparin cofactor II (HCII), a key serpin present in human plasma, remain unknown. Using a computational strategy on a library of 46 656 heparan sulfate hexasaccharides we identified a rare sequence consisting of consecutive glucuronic acid 2-O-sulfate residues as selectively targeting HCII. This and four other unique hexasaccharides were chemically synthesized. The designed sequence was found to activate HCII ca. 250-fold, while leaving aside antithrombin, a closely related serpin, essentially unactivated. This group of rare designed hexasaccharides will help understand HCII function. More importantly, our results show for the first time that rigorous use of computational techniques can lead to discovery of unique GAG sequences that can selectively target GAG-binding protein(s), which may lead to chemical biology or drug discovery tools.
Asunto(s)
Glucuronatos/farmacología , Cofactor II de Heparina/agonistas , Heparitina Sulfato/farmacología , Descubrimiento de Drogas , Glucuronatos/química , Cofactor II de Heparina/metabolismo , Heparitina Sulfato/química , Humanos , Unión Proteica , Bibliotecas de Moléculas Pequeñas/química , Bibliotecas de Moléculas Pequeñas/farmacologíaRESUMEN
Reaction of the bis-alkenyl complex cis-[Pt(PPh3)2(CH2CH2CH=CH2)2] with Grubbs 1st generation catalyst gives, in high yield, the metallacycloalkene cis-[Pt(PPh3)2(CH2CH2CH=CHCH2CH2)], which can be hydrogenated to the metallacycloalkane cis-[Pt(PPh3)2(CH2)6].